Clinical Trial Update: Anabolic Response Cancer [NA]

View source ↗

Summary

A Texas A&M University–sponsored clinical trial (NCT02793531) investigating anabolic response in cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Texas A&M University | Conditions: Cancer | NA | Status: WITHDRAWN